VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $35,682,000 | +54.6% | 1,533,981 | +5.7% | 0.03% | +55.6% |
Q1 2018 | $23,075,000 | -31.4% | 1,450,820 | -9.8% | 0.02% | -25.0% |
Q4 2017 | $33,626,000 | +48.5% | 1,607,737 | +1.5% | 0.02% | +41.2% |
Q3 2017 | $22,638,000 | -5.3% | 1,583,651 | +10.3% | 0.02% | -10.5% |
Q2 2017 | $23,895,000 | +65.0% | 1,435,670 | +9.2% | 0.02% | +58.3% |
Q1 2017 | $14,481,000 | -19.6% | 1,314,638 | +6.0% | 0.01% | -29.4% |
Q4 2016 | $18,009,000 | -40.5% | 1,240,445 | +0.3% | 0.02% | -45.2% |
Q3 2016 | $30,281,000 | +22.5% | 1,236,273 | +0.4% | 0.03% | +19.2% |
Q2 2016 | $24,710,000 | -22.4% | 1,231,930 | +1.9% | 0.03% | -25.7% |
Q1 2016 | $31,830,000 | -73.3% | 1,209,137 | +2.8% | 0.04% | -73.9% |
Q4 2015 | $118,992,000 | -45.8% | 1,175,890 | -4.8% | 0.13% | -49.8% |
Q3 2015 | $219,389,000 | -12.7% | 1,234,903 | +9.1% | 0.27% | -9.5% |
Q2 2015 | $251,309,000 | +14.9% | 1,132,364 | +2.3% | 0.30% | +13.0% |
Q1 2015 | $218,657,000 | +34.6% | 1,106,733 | -2.2% | 0.26% | +36.6% |
Q4 2014 | $162,475,000 | +6.1% | 1,131,440 | -2.9% | 0.19% | +3.8% |
Q3 2014 | $153,091,000 | +0.3% | 1,165,806 | -3.2% | 0.18% | +3.4% |
Q2 2014 | $152,623,000 | -3.1% | 1,204,663 | +0.8% | 0.18% | -6.8% |
Q1 2014 | $157,464,000 | +9.2% | 1,194,957 | -2.8% | 0.19% | +9.8% |
Q4 2013 | $144,177,000 | +12.4% | 1,229,228 | +0.1% | 0.17% | +3.0% |
Q3 2013 | $128,251,000 | +28.6% | 1,227,475 | +5.8% | 0.17% | +22.5% |
Q2 2013 | $99,692,000 | – | 1,159,763 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |